Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Tafamidis meglumine 20mg capsules |
| BNF code | 0409030S0AAAAAA |
| Virtual Therapeutic Moiety | Tafamidis |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 30 Jun 2020 |
| Previous name | Tafamidis 20mg capsules |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Tafamidis meglumine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 20.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | capsule.oral |
| Dose Form | |
| Formulation | Oral capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Vyndaqel 20mg capsules (Pfizer Ltd) | |
| Virtual Medicinal Product Packs | |
| Tafamidis meglumine 20mg capsules 30 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.